Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.52 EUR | -0.71% | +0.39% | -0.27% |
05-24 | Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi | MT |
05-24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.27% | 121B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Transcript : Sanofi Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 10